Label: GADAVYT LOPERAMIDE HCL- loperamide hydrochloride liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated May 22, 2013

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    Active Ingredient (in each 5mL teaspoonful)            Purpose

    Loperamide HCl, 1mg ....................................................Antidiarrheal

  • PURPOSE

    Purpose

    Antidiarrheal

  • INDICATIONS & USAGE

    Uses

    controls the symptoms of diarrhea, including Traveler's Diarrhea.

  • WARNINGS

    Warnings

    Allergy Alert:Do not use if you have ever had a rash or other allergic reaction to Loperamide HCl.

  • DO NOT USE

    Do not use if you have bloody or black stool

    Ask a Doctor before use if you have

    • high fiver (greater than 101 degrees F)
    • mucus present in your stool
    • a history of liver disease
      Ask a doctor or pharmacist before use if you are taking antibiotics
    Stop use and ask a doctor if diarrhea lasts for more than 2 days
  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. In case of overdose, get medical help or contact Poison Control Center right away.

  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding,ask a health professional before use

  • DOSAGE & ADMINISTRATION

    Directions

    Use enclosed dosage cup to accurately measure dosage as noted below

    • drink plenty of clear fluids to help prevent dehydration, which may accompany diarrhea
    • find right dosage on chart
    • if possible, use weight to dose; otherwise, use age.

    Adults and children 12 years and older
    4 teaspoonfuls (1 dosage cup) after the first loose bowel movement;
    2 teaspoonfuls (1/2 dosage cup) after each subsequent loose bowel movement;
    but no more than 8 teaspoonfuls a day
    Children 9-11 (60-95 lbs)
    2 teaspoonfuls (1/2 dosage cup) after the first loose bowel movement;
    1 teaspoonful (1/4 dosage cup) after each subsequent loose bowel movement;
    but no more than 6 teaspoonfuls a day
    Children 6-8 (48-59 lbs)
    2 teaspoonfuls (1/2 dosage cup) after the first loose bowel movement;
    1 teaspoonfuls (1/4 dosage cup) after each subsequent loose bowel movement;
    but no more than 4 teaspoonfuls a day
    Children under 6 years (Up to 47 lbs)
    Ask a doctor (not intended for use in children under 6 years old
  • INACTIVE INGREDIENT

    Inactive ingredients

    citric acid, propylene glycol, methylparaben, propylparaben, glycerin, sucralose, cherry flavor, peppermint flavor, sorbitol, purified water

  • QUESTIONS

    Questions or comments?

    Call 305-382-3288

    www.gadallaboratories.com

  • PRINCIPAL DISPLAY PANEL

    loperamide
  • INGREDIENTS AND APPEARANCE
    GADAVYT LOPERAMIDE HCL 
    loperamide hydrochloride liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:53113-657
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LOPERAMIDE HYDROCHLORIDE (UNII: 77TI35393C) (LOPERAMIDE - UNII:6X9OC3H4II) LOPERAMIDE HYDROCHLORIDE1 mg  in 5 mL
    Inactive Ingredients
    Ingredient NameStrength
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    SUCRALOSE (UNII: 96K6UQ3ZD4)  
    SORBITOL (UNII: 506T60A25R)  
    WATER (UNII: 059QF0KO0R)  
    Product Characteristics
    Color    Score    
    ShapeSize
    FlavorCHERRY (Cherry) , MINT (Mint) Imprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:53113-657-041 in 1 CARTON
    1118 mL in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other05/01/2013
    Labeler - Gadal Laboratories Inc (841305639)